|
Apr 2
|
Bristol Myers Squibb (BMY) Stock Moves -0.47%: What You Should Know
|
|
Apr 2
|
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
|
|
Apr 1
|
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
|
|
Jan 16
|
Bristol Myers Squibb (BMY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Jan 10
|
Prothena's (PRTA) Update on Pipeline Progress Disappoints
|
|
Jan 10
|
5 questions facing pharma in 2024
|